Immunocore Holdings PLC - ADR
General ticker "IMCR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.5B
Immunocore Holdings PLC - ADR does not follow the US Stock Market performance with the rate: -36.7%.
Estimated limits based on current volatility of 2.5%: low 27.66$, high 29.08$
Factors to consider:
- US accounted for 71.1% of revenue in the fiscal year ended 2023-12-31
- Current price 39.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [46.80$, 76.92$]
- 2024-12-30 to 2025-12-30 estimated range: [44.88$, 74.82$]
Short-term IMCR quotes
Long-term IMCR plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $249.43MM |
| Operating Expenses | $309.08MM |
| Operating Income | $-59.65MM |
| Non-Operating Income | $-1.24MM |
| Interest Expense | $5.15MM |
| R&D Expense | $163.54MM |
| Income(Loss) | $-60.89MM |
| Taxes | $-5.60MM |
| Profit(Loss) | $-55.29MM |
| Stockholders Equity | $368.84MM |
| Inventory | $4.50MM |
| Assets | $597.00MM |
| Operating Cash Flow | $2.94MM |
| Capital expenditure | $5.42MM |
| Investing Cash Flow | $-5.42MM |
| Financing Cash Flow | $34.35MM |
| Earnings Per Share* | $-1.13 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.